Shamir Mehta
PHRI Senior Scientist Shamir Mehta received the Canadian Association of Interventional Cardiology (CAIC) Outstanding Achievement Award for his excellence in clinical practice, education, research, and leadership in interventional cardiology.
The award was presented at the CAIC Annual General Meeting as part of the Canadian Cardiovascular Congress 2024, which took place on October 24 in Vancouver.
“I’m honored to receive the Canadian Association of Interventional Cardiology Outstanding Achievement Award. This award was made possible because of the support of my colleagues, mentors, fellows, collaborators and the research teams I have had the privilege to work with all these years,” said Mehta.
“I am proud of the high caliber research we conduct at the Population Health Research Institute, and I am grateful to HHS and McMaster for their unwavering support and encouragement.”
Mehta leads the Acute Coronary Syndrome and Interventional Cardiology research program at PHRI, focusing on the role and timing of invasive therapies in patients with acute ischemic heart disease and evaluating new antiplatelet and anticoagulant therapies. He has led large pragmatic randomized trials assessing invasive interventional strategies for acute coronary syndromes. He has also led multinational randomized trials to improve outcomes for heart-attack patients.
He was the Principal Investigator of the PHRI PCI-CURE study, which established the benefit of clopidogrel in patients undergoing PCI, and the CURRENT-OASIS 7 trial evaluating aspirin and clopidogrel dosing. He also leads PREMISE, a Canadian multicenter registry for patients undergoing percutaneous mitral valve repair with the Mitraclip.
Mehta led the landmark COMPLETE trial, which evaluated a strategy of complete revascularization in patients with STEMI and multivessel disease. This trial was recognized by the editors of the New England Journal of Medicine as one of its Most Notable Articles of 2019 and informed the 2021 guidelines for coronary artery revascularization published by ACC/AHA/SCAI.
In 2022, Mehta received the CCS Research Achievement Award, and in 2021, he was awarded the Douglas Holder/PHRI Chair in interventional cardiology, a $2 million endowment to support his groundbreaking research.
